Chandrashekhar Mukund Shrikhande

Chandrashekhar Mukund Shrikhande

Active Director Director DIN 01856571
DIN 01856571 First appointment Aug 2008 Primary industry Service
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Chandrashekhar Mukund Shrikhande

Data last updated:

Chandrashekhar Mukund Shrikhande is a Director at Clinical Ethics Forum (since 2008). The company operates in Service.

DIN 01856571
Primary Designation Director
Industry Service
First Appointment 28 Aug 2008
Oldest Company Age 18 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Clinical Ethics Forum U85100MH2008NPL186290
Director28 Aug 20082008Active

Board colleagues of Chandrashekhar Mukund Shrikhande

NameDINCompanyDesignation
Anjali Jitendra Bapat01856591Clinical Ethics ForumDirector

Directorship timeline

Open interactive timeline →
Clinical Ethics Forum
Premium access

Shareholding and investment profile for Chandrashekhar Mukund Shrikhande

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandrashekhar Mukund Shrikhande

Chandrashekhar Mukund Shrikhande currently holds 1 directorship: Clinical Ethics Forum (Director, since 28 Aug 2008).

Chandrashekhar Mukund Shrikhande was first appointed on 28 Aug 2008 as Director at Clinical Ethics Forum.

The current boards of Chandrashekhar Mukund Shrikhande's companies include Anjali Jitendra Bapat (Clinical Ethics Forum).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available